APA (7th ed.) Citation

Yoshikawa, T., Furukawa, T., Hashimoto, T., Azuma, N., & Matsui, K. (2024). Association of Baseline Serum Soluble Tumour Necrosis Factor Receptor Levels with the Response of Rheumatoid Arthritis to Janus Kinase Inhibitor Therapy. International Journal of Rheumatology, 2024, 1. https://doi.org/10.1155/2024/2898586

Chicago Style (17th ed.) Citation

Yoshikawa, Takahiro, Tetsuya Furukawa, Teppei Hashimoto, Naoto Azuma, and Kiyoshi Matsui. "Association of Baseline Serum Soluble Tumour Necrosis Factor Receptor Levels with the Response of Rheumatoid Arthritis to Janus Kinase Inhibitor Therapy." International Journal of Rheumatology 2024 (2024): 1. https://doi.org/10.1155/2024/2898586.

MLA (9th ed.) Citation

Yoshikawa, Takahiro, et al. "Association of Baseline Serum Soluble Tumour Necrosis Factor Receptor Levels with the Response of Rheumatoid Arthritis to Janus Kinase Inhibitor Therapy." International Journal of Rheumatology, vol. 2024, 2024, p. 1, https://doi.org/10.1155/2024/2898586.